• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

Pain Management

GTX Medical wins FDA breakthrough device designation for targeted epidural spinal stimulation

June 9, 2020 By Danielle Kirsh

GTX Medical this week said it received FDA breakthrough device designation for its Go-2 targeted epidural spinal stimulation system. The system is designed to promote the recovery of leg motor functions and neurological control in adults that have spinal cord injuries and paralysis. It improves the reconnection of the brain with paralyzed muscles and individuals […]

Filed Under: Food & Drug Administration (FDA), Pain Management Tagged With: GTX Medical

Nevro Senza Omnia SCS wins CE Mark

May 14, 2020 By Nancy Crotti

Nevro (NYSE:NVRO) announced today that it has received CE mark approval for the Senza Omnia spinal cord stimulation (SCS) system. The system won FDA approval in November 2019. It is is the first and only SCS system designed to deliver Nevro’s proprietary HF10 therapy, as well as other available SCS frequencies, according to the company. Redwood […]

Filed Under: Business/Financial News, Featured, Neuromodulation/Neurostimulation, Pain Management, Regulatory/Compliance, Wall Street Beat Tagged With: CE Mark, Nevro Corp.

Avanos up on Street-beating Q1

May 6, 2020 By Sean Whooley

Avanos Medical (NYSE:AVNS) shares ticked up today on first-quarter results that topped the consensus forecast. The Alpharetta, Ga.-based company posted profits of $3.7 million, or 8¢ per share, on sales of $180.4 million for the three months ended March 31, 2020, recording profits after a $20.3 million loss this time last year on sales growth of […]

Filed Under: Business/Financial News, MassDevice Earnings Roundup, Pain Management, Respiratory, Wall Street Beat Tagged With: Avanos Medical (formerly Halyard Health), coronavirus, COVID-19

NeuroMetrix dips on Q1 losses

April 23, 2020 By Sean Whooley

NeuroMetrix (NSDQ:NURO) shares fell today on first-quarter losses that reflected the impact of COVID-19 on its business. The Woburn, Mass.-based pain-treating transcutaneous electrical nerve stimulation (TENS) device developer posted losses of -$657,371 on sales of $2.2 million for the three months ended March 31, 2020, seeing its bottom line slide into the red from profits of […]

Filed Under: Business/Financial News, Featured, MassDevice Earnings Roundup, Neuromodulation/Neurostimulation, Pain Management, Wall Street Beat Tagged With: Neurometrix

NeuroMetrix settles $4m false advertising case with FTC

March 4, 2020 By Nancy Crotti

Pain-treating TENS device company NeuroMetrix (NSDQ:NURO) has agreed to pay at least $4 million to settle a false advertising case brought by the Federal Trade Commission FTC. The commission said today that the Woburn, Mass.-based company also agreed to stop making deceptive claims that its Quell device treats pain throughout the body when placed below the […]

Filed Under: Business/Financial News, Featured, Legal News, Neuromodulation/Neurostimulation, Pain Management Tagged With: Federal Trade Commission (FTC), Neurometrix

Stimwave caves in patent spat with Nevro

February 28, 2020 By Nancy Crotti

Stimwave today announced it will cease all sales of its high-frequency spinal cord stimulation systems in exchange for dismissal of a patent infringement lawsuit brought by rival Nevro (NYSE:NVRO). No damages were awarded to Nevro under the settlement. Redwood City, Calif.-based Nevro brought the suit in February 2019, alleging that Stimwave infringed on patents related to […]

Filed Under: Business/Financial News, Featured, Legal News, Neuromodulation/Neurostimulation, Pain Management, Patent Infringement Tagged With: Nevro Corp., Stimwave

Dyve Biosciences enrolls first patient in gout trial

February 20, 2020 By Sean Whooley

Dyve Biosciences announced today that it enrolled its first patient in the Phase 2 clinical study of its DYV-700 topically administered therapeutic for acute gout treatment. Thousand Oaks, Calif.–based Dyve won FDA clearance to begin the Targets Phase 2 trial in December 2019. The double-blind, placebo-controlled, randomized clinical trial is set to evaluate the efficacy […]

Filed Under: Clinical Trials, Drug-Device Combinations, Pain Management Tagged With: dyvebioscience

NANS 2020: Neuromodulation news you need to know

January 24, 2020 By Nancy Crotti

Neuromodulation devices from companies including Medtronic (NYSE:MDT), Abbott (NYSE:ABT) and SPR Therapeutics are showing promise treating pain. That’s one of the initial takeaways from study results that medical device companies in the neuromodulation space are touting this weekend at NANS 2020 in Las Vegas. NANS is a joint conference of Congress of Neurological Surgeons and the […]

Filed Under: Featured, Neuromodulation/Neurostimulation, Pain Management, Research & Development Tagged With: Abbott, Medtronic, NANS 2020, SPR Therapeutics

Medtronic touts 3-month clinical trial results using Stimgenics spinal cord stimulation

January 23, 2020 By Danielle Kirsh

Medtronic (NYSE:MDT) this week touted results from a three-month clinical trial of the recently acquired Stimgenics Differential Target Multiplexed Spinal Cord Stimulation using Medtronic’s Intellis platform. The large, multicenter randomized controlled trial showed that 80% of patients with chronic back pain that were treated with Differential Target Multiplexed (DTM) reported at least 50% pain relief […]

Filed Under: Neurological, Neuromodulation/Neurostimulation, Pain Management Tagged With: Medtronic

Medtronic acquires Stimgenics

January 9, 2020 By Danielle Kirsh

Medtronic (NYSE:MDT) yesterday said it acquired spinal cord stimulation company Stimgenics for an undisclosed amount. Stimgenics has developed a spinal cord stimulation waveform known as Differential Target Multiplexed Spinal Cord Stimulation. The therapy is delivered through Medtronic’s Intellis platform and is a chronic pain treatment option. “Stimgenics’s research is deeply rooted in clinical science that began […]

Filed Under: Business/Financial News, Featured, Mergers & Acquisitions, Neuromodulation/Neurostimulation, Pain Management Tagged With: Medtronic, Stimgenics

BioNess wins CE Mark for StimRouter neuromod system

January 6, 2020 By Sean Whooley

BioNess announced today that it won CE Mark approval for its StimRouter neuromodulation system indicated for the treatment of fecal incontinence. The StimRouter system previously won approval for treating chronic pain and overactive bladder. The small implantable system targets the tibial nerve near the ankle. Patients undergoing the StimRouter implant procedure receive one incision as […]

Filed Under: Featured, Neuromodulation/Neurostimulation, Pain Management, Regulatory/Compliance Tagged With: Bioness, CE Mark

  • « Go to Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Go to page 5
  • Interim pages omitted …
  • Go to page 37
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS